Editas Medicine, Inc. (NASDAQ:EDIT)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $47.0M
- Net income
- -$73.9M
- Net margin
- -157.3%
Little or no net debt.
- Total debt
- $15.5M
- Cash
- $181.8M
- Debt / equity
- 0.15
Comfortably covers what is due within a year.
- Current assets
- $218.1M
- Current liabilities
- $68.4M
- Current ratio
- 3.19
Consumes cash and must keep raising it.
- Operating cash flow
- -$119.9M
- Free cash flow
- -$120.5M
- FCF margin
- -256.5%
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 119.3M
- Share growth (1y)
- 41.3%
- Cash runway
- 18 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EDIT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 11.89 M | 2.83 M | 24.74 M | 7.54 M | 3.58 M | 4.66 M |
| Revenue Growth (YoY) | 232.31 % | -39.22 % | -19.16 % | 12265.57 % | 597.47 % | 310.40 % |
| Cost of Revenue | 0.00 | 483.00 K | 0.00 | 19.77 M | 16.18 M | 26.59 M |
| Gross Profit | 11.89 M | 2.35 M | 24.74 M | -12.23 M | -12.60 M | -21.93 M |
| SG&A Expense | 11.60 M | 10.23 M | 11.35 M | 12.32 M | 12.86 M | 13.38 M |
| R&D Expense | 20.18 M | 2.83 M | 27.40 M | 19.77 M | 16.18 M | 26.59 M |
| Operating Expenses | 30.44 M | 27.35 M | 38.76 M | 12.32 M | 38.94 M | 54.23 M |
| Operating Income | -18.55 M | -25.00 M | -14.02 M | -24.55 M | -51.54 M | -76.16 M |
| Pretax Income | -18.23 M | -24.98 M | -5.62 M | -25.12 M | -53.23 M | -76.09 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -18.23 M | -24.98 M | -5.62 M | -25.12 M | -53.23 M | -76.09 M |
| EPS (Basic) | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 |
| EPS (Diluted) | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 |
| Shares Outstanding | 119.29 M | 97.88 M | 88.75 M | 90.09 M | 84.41 M | 83.06 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.